Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lynn A. Sleeper, Sc.D.

Co-Author

This page shows the publications co-authored by Lynn Sleeper and Steven Colan.
Connection Strength

3.514
  1. Longitudinal Variation in Presence and Severity of Cardiac Valve Regurgitation in Healthy Children. J Am Soc Echocardiogr. 2020 11; 33(11):1400-1406.
    View in: PubMed
    Score: 0.944
  2. Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy. J Pediatr. 2016 Mar; 170:173-80.e1-4.
    View in: PubMed
    Score: 0.171
  3. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012 Aug; 25(8):842-854.e6.
    View in: PubMed
    Score: 0.134
  4. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3.
    View in: PubMed
    Score: 0.121
  5. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. 2009 Nov; 2(6):591-8.
    View in: PubMed
    Score: 0.111
  6. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007 Feb 13; 115(6):773-81.
    View in: PubMed
    Score: 0.093
  7. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J. 2006 Sep; 152(3):427-33.
    View in: PubMed
    Score: 0.090
  8. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003 Apr 24; 348(17):1647-55.
    View in: PubMed
    Score: 0.071
  9. Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study. J Am Heart Assoc. 2021 May 04; 10(9):e017731.
    View in: PubMed
    Score: 0.062
  10. Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta. Am J Cardiol. 2021 04 01; 144:111-117.
    View in: PubMed
    Score: 0.061
  11. Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry. Prog Pediatr Cardiol. 2019 Jun; 53:1-10.
    View in: PubMed
    Score: 0.054
  12. Normal Values for Left Ventricular Strain and Synchrony in Children Based on Speckle Tracking Echocardiography. Am J Cardiol. 2019 05 01; 123(9):1546-1554.
    View in: PubMed
    Score: 0.053
  13. Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study. Circulation. 2018 07 03; 138(1):29-36.
    View in: PubMed
    Score: 0.050
  14. Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome. Am J Cardiol. 2018 05 01; 121(9):1094-1101.
    View in: PubMed
    Score: 0.050
  15. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy. Open Heart. 2017; 4(2):e000615.
    View in: PubMed
    Score: 0.049
  16. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. JAMA Cardiol. 2017 04 01; 2(4):419-428.
    View in: PubMed
    Score: 0.047
  17. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group. Circ Heart Fail. 2017 Feb; 10(2).
    View in: PubMed
    Score: 0.046
  18. Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure. J Am Soc Echocardiogr. 2016 11; 29(11):1066-1073.
    View in: PubMed
    Score: 0.045
  19. Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy. J Appl Physiol (1985). 2016 Jun 01; 120(11):1301-18.
    View in: PubMed
    Score: 0.043
  20. Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Pediatr Nephrol. 2015 Dec; 30(12):2177-88.
    View in: PubMed
    Score: 0.042
  21. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. J Card Fail. 2015 Nov; 21(11):877-84.
    View in: PubMed
    Score: 0.042
  22. The reproducibility and absolute values of echocardiographic measurements of left ventricular size and function in children are algorithm dependent. J Am Soc Echocardiogr. 2015 May; 28(5):549-558.e1.
    View in: PubMed
    Score: 0.041
  23. Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27; 371(22):2061-71.
    View in: PubMed
    Score: 0.040
  24. Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial. J Am Heart Assoc. 2014 Jun 23; 3(3):e000079.
    View in: PubMed
    Score: 0.039
  25. Technical performance score is associated with outcomes after the Norwood procedure. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):2208-13, 2214.e1-6.
    View in: PubMed
    Score: 0.039
  26. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol. 2014 Apr 15; 63(14):1405-13.
    View in: PubMed
    Score: 0.038
  27. Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol. 2014 Apr; 35(4):658-67.
    View in: PubMed
    Score: 0.037
  28. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013 Nov; 6(6):1214-22.
    View in: PubMed
    Score: 0.037
  29. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet. 2013 Dec 07; 382(9908):1889-97.
    View in: PubMed
    Score: 0.037
  30. Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome. J Am Soc Echocardiogr. 2013 Jun; 26(6):657-66.
    View in: PubMed
    Score: 0.036
  31. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2012 Sep; 164(3):442-8.
    View in: PubMed
    Score: 0.034
  32. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation. 2012 Sep 04; 126(10):1237-44.
    View in: PubMed
    Score: 0.034
  33. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol. 2012 Feb 07; 59(6):607-15.
    View in: PubMed
    Score: 0.033
  34. Non-geometric echocardiographic indices of ventricular function in patients with a Fontan circulation. J Am Soc Echocardiogr. 2011 Nov; 24(11):1213-9.
    View in: PubMed
    Score: 0.032
  35. Challenges in echocardiographic assessment of mitral regurgitation in children after repair of atrioventricular septal defect. Pediatr Cardiol. 2012 Feb; 33(2):205-14.
    View in: PubMed
    Score: 0.032
  36. Surgical interventions for atrioventricular septal defect subtypes: the pediatric heart network experience. Ann Thorac Surg. 2011 Oct; 92(4):1468-75; discussion 1475.
    View in: PubMed
    Score: 0.032
  37. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation. 2011 Aug 16; 124(7):814-23.
    View in: PubMed
    Score: 0.032
  38. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation. 2011 May 31; 123(21):2353-62.
    View in: PubMed
    Score: 0.031
  39. Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J. 2011 Feb; 161(2):233-40.
    View in: PubMed
    Score: 0.031
  40. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011 Jan 04; 57(1):86-92.
    View in: PubMed
    Score: 0.030
  41. Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J. 2011 Jan; 161(1):13-67.
    View in: PubMed
    Score: 0.030
  42. Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr. 2011 Jan; 24(1):53-9.
    View in: PubMed
    Score: 0.030
  43. Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1371-9.
    View in: PubMed
    Score: 0.030
  44. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010 Oct; 6(4):401-13, vii.
    View in: PubMed
    Score: 0.030
  45. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010 Nov; 3(6):689-97.
    View in: PubMed
    Score: 0.030
  46. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med. 2010 May 27; 362(21):1980-92.
    View in: PubMed
    Score: 0.029
  47. Partial and transitional atrioventricular septal defect outcomes. Ann Thorac Surg. 2010 Feb; 89(2):530-6.
    View in: PubMed
    Score: 0.029
  48. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation. 2010 Jan 05; 121(1):34-42.
    View in: PubMed
    Score: 0.028
  49. Functional state following the Fontan procedure. Cardiol Young. 2009 Aug; 19(4):320-30.
    View in: PubMed
    Score: 0.027
  50. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009 Jul 15; 104(2):281-6.
    View in: PubMed
    Score: 0.027
  51. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008 Jul 08; 52(2):85-98.
    View in: PubMed
    Score: 0.026
  52. Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):968-75.
    View in: PubMed
    Score: 0.025
  53. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2008 Jun; 155(6):998-1005.
    View in: PubMed
    Score: 0.025
  54. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40.
    View in: PubMed
    Score: 0.024
  55. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75.
    View in: PubMed
    Score: 0.023
  56. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006 Oct 18; 296(15):1867-76.
    View in: PubMed
    Score: 0.023
  57. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics. 2006 Oct; 118(4):1519-31.
    View in: PubMed
    Score: 0.023
  58. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000 Feb; 139(2 Pt 3):S86-95.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.